Zobrazeno 21 - 30
of 37
pro vyhledávání: '"Beka Solomon"'
Publikováno v:
Alzheimer's & Dementia. 7
Background: Cerebral amyloid angiopathy (CAA) is a neurological condition in which amyloid protein builds up on the walls of the arteries in the brain, increasing the risk of hemorrhagic stroke. Deposits of amyloidb (Ab)protein are found in thewalls
Autor:
Beka Solomon, Inna Rabinovich-Nikitin
Publikováno v:
Neurobiology of Aging. 35:S20-S21
Autor:
Beka Solomon
Publikováno v:
Alzheimer's & Dementia. 6
Publikováno v:
Diabetes Care. 15:1451-1454
OBJECTIVE To develop a reliable, simple, and sensitive assay for microalbuminuria, based on covalent attachment of anti-HSA to oxirane-bearing polymethylmethacrylate beads (Eupergit CB6200). RESEARCH DESIGN AND METHODS Anti-HSA antibodies were couple
Autor:
Beka Solomon
Publikováno v:
Drugs of today (Barcelona, Spain : 1998). 43(5)
The pathology of Alzheimer's disease shows a significant correlation between beta-amyloid peptide conformation and the clinical severity of dementia. For many years efforts have been focused on the development of inhibitors of beta-amyloid formation
Autor:
Beka Solomon
Publikováno v:
Expert opinion on investigational drugs. 16(6)
Recent clinical trials of active vaccination against beta-amyloid (Abeta) have succeeded in clearing Abeta plaques; however, further understanding of immunization with regards to inflammation and other hallmarks of Alzheimer's disease pathology is re
Autor:
Beka Solomon
Publikováno v:
Journal of Alzheimer's disease : JAD. 9
Site-directed antibodies which modulate conformation of amyloid-beta peptide (Abeta) became the theoretical basis of the immunological approach for treatment of Alzheimer's disease (AD). Indeed, antibodies towards the EFRH sequence, located between a
Publikováno v:
Journal of neuroscience research. 84(2)
Intravenous immunoglobulin (IVIg), a purified immunoglobulin fraction manufactured from the blood of healthy humans, is an FDA-approved treatment for many immune and inflammatory diseases. Recent studies have demonstrated that IVIg therapy has severa
Autor:
Beka Solomon
The pathology of Alzheimer's disease (AD) shows a significant correlation between β-amyloid peptide (AβP) deposition and severity of dementia. We have shown that antibodies toward the N-terminal region of β-amyloid peptide suppress in vitro and in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::218954efb52508139b0c3092ddaa9717
https://doi.org/10.1016/b978-012369442-3/50079-9
https://doi.org/10.1016/b978-012369442-3/50079-9
Autor:
Beka Solomon
Publikováno v:
Current Alzheimer research. 1(3)
Site-directed antibodies which modulate conformation of beta-amyloid peptide became the theoretical basis of the immunological approach for treatment of Alzheimer's disease (AD). Indeed, antibodies towards the EFRH sequence, located between amino aci